Step 2 | Step 3 | |
---|---|---|
Select target behavior | Specify target behavior | |
Consider | Who? | Urologist |
What? | Clinical trial as a treatment option | |
When? | Prior to treatment decision | |
Where? | At location of results review | |
How often? | At each cancer diagnosis | |
With whom? | Each diagnosed cancer patient | |
Counsel | Who? | Urologist |
What? | Clinical trials are a treatment option | |
When? | At first treatment counseling visit | |
Where? | In the exam room | |
How often? | Every initial cancer treatment counseling visit | |
With whom? | All patients meeting broad eligibility criteria (determined by flow sheet) | |
Refer | Who? | Urologist |
What? | Signal to patient and cancer program that patient is recommended for clinical trial eligibility screening | |
When? | During and immediately following treatment counseling visit | |
Where? | Exam room and location where charting is performed | |
How often? | Each time clinical trial is included in treatment counseling | |
With whom? | All patients meeting broad eligibility criteria (determined by flow sheet) who do not refuse referral | |
Notify | Who? | Urologist or designated clinic staff |
What? | Cancer patient is scheduling visit for clinical trial eligibility screening | |
When? | At patient’s convenience in next 3 weeks | |
Where? | Immediately following treatment counseling visit | |
How often? | Each time referral is documented | |
With whom? | All patients meeting broad eligibility criteria (determined by flow sheet) who do not refuse referral |